A Study Evaluating the Safety and Efficacy of Rituximab in Patients With Myasthenia Gravis
A Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating the Safety and Efficacy of Rituximab (Mabthera®) in Patients With New Onset Generalized Myasthenia Gravis (MG) A Randomized, Double-blind, Placebo-controlled Multicenter Study Evaluating the Safety and Efficacy ...
A clinical trial investigating the effect and safety of the drug rituximab in patients with new onset myasthenia gravis, an autoimmune condition affecting muscle strenght A clinical trial investigating the effect and safety of the drug rituximab in patients with new onse ...
A randomized, doubleblind, placebo-controlled multicenter trial to evaluate the safety and efficacy of rituximab (Mabthera) in subjects with new onset myasthenia gravis; the RINOMAX study - Rinomax A randomized, doubleblind, placebo-controlled multicenter trial to evaluate the safety and efficacy ...
New onset myasthenia gravis MedDRA version: 20.0;Level: SOC;Classification code 10029205;Term: Nervous system disorders;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] New onset myasthenia gravis MedDRA version: 20.0;Level: SOC;Classification code 10029205;Term: Nervo ...